戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cular block, long-cycle length TdP, and slow monomorphic ventricular tachycardia.
2  VF episode and another developed sustained, monomorphic ventricular tachycardia.
3 rate for initiation of both VF and sustained monomorphic ventricular tachycardia.
4 hich patients would have inducible sustained monomorphic ventricular tachycardia.
5 tricular tachycardia or difficult to control monomorphic ventricular tachycardia.
6 iologic study attempting to induce sustained monomorphic ventricular tachycardia.
7 CD cannot provide antitachycardia pacing for monomorphic ventricular tachycardia.
8 d the study, 33 patients developed sustained monomorphic ventricular tachycardia, 16 died suddenly, a
9  but also provide antitachycardia pacing for monomorphic ventricular tachycardia and antibradycardia
10 ecutive patients with hemodynamically stable monomorphic ventricular tachycardia and coronary artery
11 trioventricular nodal reentrant tachycardia, monomorphic ventricular tachycardia, and Brugada syndrom
12 of ARVC, hemodynamically tolerated sustained monomorphic ventricular tachycardia, and male sex predic
13                      Patients with sustained monomorphic ventricular tachycardia associated with coro
14 ominantly because of their symptoms; others (monomorphic ventricular tachycardia, Brugada syndrome, t
15 ator was implanted for a positive (inducible monomorphic ventricular tachycardia) but not a negative
16 g attempt successfully terminated 46% of all monomorphic ventricular tachycardias, but accelerated th
17 On paired comparison, phase sequences during monomorphic ventricular tachycardia correlated moderatel
18 es were related to inducibility of sustained monomorphic ventricular tachycardia during electrophysio
19  in those who received their first shock for monomorphic ventricular tachycardia (hazard ratio [HR]:
20                                              Monomorphic ventricular tachycardia (hazard ratio, 4.6 [
21  0.028), hemodynamically tolerated sustained monomorphic ventricular tachycardia (HR: 2.19; p = 0.023
22     Ventricular stimulation led to sustained monomorphic ventricular tachycardia in 36 patients, nons
23  been useful in guiding catheter ablation of monomorphic ventricular tachycardia in patients with cor
24 target the critical isthmuses for re-entrant monomorphic ventricular tachycardia in tetralogy of Fall
25 icular arrhythmias were classified either as monomorphic ventricular tachycardia (MVT) or polymorphic
26    Programmed electric stimulation to induce monomorphic ventricular tachycardia (MVT) was used to as
27 ystole (n=102), organized rhythm (n=120), or monomorphic ventricular tachycardia (n=4).
28 as strongly associated with inducibility for monomorphic ventricular tachycardia (noninducible versus
29 presence of a SB led most often to sustained monomorphic ventricular tachycardia rather than to VF, w
30  hospitalization duration, 6-month sustained monomorphic ventricular tachycardia recurrence, quality
31 0% (114 of 184) of patients had no sustained monomorphic ventricular tachycardia recurrence; the prop
32                           Notably, recurrent monomorphic ventricular tachycardia requiring >/=2 impla
33 ft ventricular sites of origin of repetitive monomorphic ventricular tachycardia (RMVT).
34     Sudden cardiac death (SCD) and sustained monomorphic ventricular tachycardia (SMVT) are frequentl
35         The results of ablation of sustained monomorphic ventricular tachycardia (SMVT) are suboptima
36 se 84%; presenting arrhythmia with sustained monomorphic ventricular tachycardia (SMVT) in 68%.
37 inically in 3 forms: 1) paroxysmal sustained monomorphic ventricular tachycardia (SMVT), 2) repetitiv
38 isms of spontaneous termination of sustained monomorphic ventricular tachycardia (SMVT), in the posti
39    The clinical characteristics of sustained monomorphic ventricular tachycardia (SMVT), when it deve
40 ythmic risk, notably manifested as sustained monomorphic ventricular tachycardia (SMVT).
41 natomical obstacles in the heart and lead to monomorphic ventricular tachycardia that can degenerate
42 those with discrete mechanisms for reentrant monomorphic ventricular tachycardia (VT) (Group A) and t
43                      The causes of sustained monomorphic ventricular tachycardia (VT) after cardiac v
44                     The arrhythmia was rapid monomorphic ventricular tachycardia (VT) in 70% of episo
45  percutaneous catheter ablation of sustained monomorphic ventricular tachycardia (VT) in LMNA cardiom
46 dial tissue can help predict inducibility of monomorphic ventricular tachycardia (VT) in patients wit
47 ) catheter ablation is effective therapy for monomorphic ventricular tachycardia (VT) in patients wit
48 terenol (100 nmol/L) alone induced sustained monomorphic ventricular tachycardia (VT) that originated
49         In catheter ablation of scar-related monomorphic ventricular tachycardia (VT), substrate volt
50  total mortality for patients with inducible monomorphic ventricular tachycardia was significantly hi
51                                    Inducible monomorphic ventricular tachycardia was the most common
52 tachycardia <170 bpm or refractory recurrent monomorphic ventricular tachycardia were excluded.
53 nimals with reproducibly inducible sustained monomorphic ventricular tachycardia were randomized 2:1: